Tag Archives: Autolus Therapeutics Plc

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Autolus Therapeutics Plc (NASDAQ: AUTL) and Cryolife (NYSE: CRY)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Autolus Therapeutics Plc (AUTL – Research Report) and Cryolife (CRY – Research Report). Autolus Therapeutics Plc (AUTL) H.C. Wainwright analyst Debjit Chattopadhyay maintained

William Blair Thinks Autolus Therapeutics Plc’s Stock is Going to Recover

In a report released yesterday, Matt Phipps from William Blair maintained a Buy rating on Autolus Therapeutics Plc (AUTL – Research Report). The company’s shares opened today at $11.33, close to its 52-week low of $10.76. Phipps said: “We believe

Autolus Therapeutics Plc (AUTL) Gets a Buy Rating from William Blair

In a report released yesterday, Matt Phipps from William Blair maintained a Buy rating on Autolus Therapeutics Plc (AUTL – Research Report). The company’s shares closed yesterday at $29.82. Phipps noted: “We believe these results compare very favorably to other

Autolus Therapeutics Plc (AUTL) Gets a Buy Rating from Wells Fargo

Wells Fargo analyst Jim Birchenough maintained a Buy rating on Autolus Therapeutics Plc (AUTL – Research Report) yesterday. The company’s shares closed yesterday at $39.93. According to TipRanks.com, Birchenough is a 5-star analyst with an average return of 22.5% and

H.C. Wainwright Believes Autolus Therapeutics Plc (NASDAQ: AUTL) Won’t Stop Here

In a report released today, Debjit Chattopadhyay from H.C. Wainwright maintained a Buy rating on Autolus Therapeutics Plc (NASDAQ: AUTL), with a price target of $45. The company’s shares opened today at $32, close to its 52-week high of $34.22.